VRA
Vera Bradley, Inc.
$3.30
+7.14%
$93.8M
No data for this timeframe.
Vol
Market Cap$93.8M
Cap SizeMicro Cap
Analyst ConsensusSell (0%)
Inst. Holders6 funds
Inst. Value$3.7M
Inst. Activity1 buys / 4 sells
SEC Reports3
Press Releases2
Recent Activity
Jun 11, 2026
earnings_calendar
VRA Q1 2027 Earnings Scheduled — 2026-06-11
Apr 24, 2026
SEC
Vera Bradley board member Carrie Tharp will not stand for re-election at the 2026 shareholder meeting due to her new rol
8-K — Impact 3/10
Apr 17, 2026
SEC
Vera Bradley terminated its shareholder rights plan (poison pill) effective April 17, 2026, by accelerating the expirati
8-K — Impact 3/10
Apr 17, 2026
Press
Vera Bradley's Board of Directors terminated its shareholder rights plan (poison pill) effective immediately, accelerati
Impact 6/10
Apr 5, 2026
Insider
Dely Mark C sold 4,174 shares
CHIEF ADMINISTRATIVE OFFICER @ $3.39 ($14.1K)
Apr 4, 2026
Insider
Bickley Ian sold 15,465 shares
Chief Executive Officer @ $3.39 ($52.4K)
Apr 4, 2026
Insider
Dely Mark C sold 9,845 shares
CHIEF ADMINISTRATIVE OFFICER @ $3.39 ($33.4K)
Mar 12, 2026
SEC
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Vera Bradley, Inc. (VRA) i
8-K — Impact 4/10
Analyst Ratings
0Strong Buy
0Buy
3Hold
4Sell
1Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 4, 2026 | Small Cap Consumer Research | REITERATE | Hold → Hold |
| Jan 26, 2026 | Small Cap Consumer Research | REITERATE | Hold → Hold |
| Jan 7, 2026 | Small Cap Consumer Research | REITERATE | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.33 | $-0.33 — $-0.33 | 8% YoY | 1 |
| Next Q | $0.01 | $0.01 — $0.01 | 150% YoY | 1 |
| Current FY | $-0.34 | $-0.34 — $-0.34 | 42% YoY | 1 |
| Next FY | $0.01 | $0.01 — $0.01 | 103% YoY | 1 |
Latest Reports
NEUTRAL
8-K
3/10
Vera Bradley board member Carrie Tharp will not stand for re-election at the 2026 shareholder meeting due to her new rol
Apr 24, 2026
NEUTRAL
8-K
3/10
Vera Bradley terminated its shareholder rights plan (poison pill) effective April 17, 2026, by accelerating the expirati
Apr 17, 2026
MIXED
Press
6/10
Vera Bradley's Board of Directors terminated its shareholder rights plan (poison pill) effective immediately, accelerati
Apr 17, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $2.7M | — |
| RENAISSANCE TECHNOLOGIES LLC | $501.5K | TRIM |
| TWO SIGMA INVESTMENTS, LP | $288.0K | ADD |
| MORGAN STANLEY | $198.9K | TRIM |
| FMR LLC | $2.6K | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 5, 2026 | Dely Mark | F | $14.1K |
| Apr 4, 2026 | Bickley Ian | F | $52.4K |
| Apr 4, 2026 | Dely Mark | F | $33.4K |
| Apr 3, 2026 | Paraie Melinda | A | $0.00 |
| Apr 3, 2026 | CASHMAN KRISTINA | A | $0.00 |
6 institutional holders with $3.7M total value (1,544,841 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, TWO. Net selling activity: 4 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,134,839 | $2.7M | 73.5% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 207,216 | $501.5K | 13.4% | TRIM -26.3% |
| 3 | TWO SIGMA INVESTMENTS, LP | 118,993 | $288.0K | 7.7% | ADD +97.5% |
| 4 | MORGAN STANLEY | 82,195 | $198.9K | 5.3% | TRIM -43.5% |
| 5 | FMR LLC | 1,091 | $2.6K | 0.1% | TRIM -59.0% |
| 6 | BANK OF AMERICA CORP /DE/ | 507 | $1.2K | 0.0% | TRIM -39.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | ADD | 60,244 | 118,993 | +97.5% | $288.0K | 2025-Q4 |
| MORGAN STANLEY | TRIM | 145,494 | 82,195 | -43.5% | $198.9K | 2025-Q4 |
| FMR LLC | TRIM | 2,661 | 1,091 | -59.0% | $2.6K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 831 | 507 | -39.0% | $1.2K | 2025-Q4 |
| Fund 1 Investments, LLC | EXIT | 2,783,155 | 0 | -100.0% | $0.00 | 2025-Q4 |
| UBS Group AG | TRIM | 287,563 | 141,268 | -50.9% | $283.9K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 60,244 | — | $121.1K | 2025-Q3 |
| FMR LLC | TRIM | 6,551 | 2,661 | -59.4% | $5.3K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 2,045 | 831 | -59.4% | $1.7K | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 271,240 | 199,940 | -26.3% | $441.9K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 164,718 | 116,904 | -29.0% | $258.4K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 16,295 | 2,045 | -87.5% | $4.5K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 14,471 | 202 | -98.6% | $446.00 | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 55,463 | 0 | -100.0% | $0.00 | 2025-Q2 |
| FMR LLC | DOUBLED | 2,636 | 5,937 | +125.2% | $13.4K | 2025-Q1 |
| CITADEL ADVISORS LLC | EXIT | 27,987 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 54,247 | 360,178 | +564.0% | $1.4M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 466,940 | 346,240 | -25.8% | $1.4M | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 68,573 | 27,987 | -59.2% | $110.0K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 69,496 | — | $379.4K | 2024-Q3 |
10 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 5, 2026 | Dely Mark C | CHIEF ADMINISTRATIVE OFFICER | F | 4,174 | $3.39 | $14.1K |
| Apr 4, 2026 | Bickley Ian | Chief Executive Officer | F | 15,465 | $3.39 | $52.4K |
| Apr 4, 2026 | Dely Mark C | CHIEF ADMINISTRATIVE OFFICER | F | 9,845 | $3.39 | $33.4K |
| Apr 3, 2026 | Paraie Melinda | Chief Branding Officer | A | 73,746 | $0.00 | $0.00 |
| Apr 3, 2026 | CASHMAN KRISTINA K | Director | A | 25,074 | $0.00 | $0.00 |
| Apr 3, 2026 | Rodriguez Jessica | Director | A | 25,074 | $0.00 | $0.00 |
| Apr 3, 2026 | Brockman Ivan | Director | A | 25,074 | $0.00 | $0.00 |
| Apr 3, 2026 | Bickley Ian | Chief Executive Officer | A | 221,239 | $0.00 | $0.00 |
| Apr 3, 2026 | Meslow Andrew | Director | A | 25,074 | $0.00 | $0.00 |
| Apr 3, 2026 | Tharp Carrie | Director | A | 25,074 | $0.00 | $0.00 |
| Apr 3, 2026 | Layding Martin | Chief Financial Officer | A | 88,496 | $0.00 | $0.00 |
| Apr 3, 2026 | Hall Robert J | Director | A | 25,074 | $0.00 | $0.00 |
| Mar 31, 2026 | Dely Mark C | CHIEF ADMINISTRATIVE OFFICER | F | 3,483 | $3.02 | $10.5K |
| Mar 31, 2026 | Dely Mark C | CHIEF ADMINISTRATIVE OFFICER | A | 22,112 | $0.00 | $0.00 |
| Mar 12, 2026 | Bickley Ian | Chief Executive Officer | A | 147,929 | $3.38 | $500.0K |
| Mar 12, 2026 | Bickley Ian | Chief Executive Officer | A | 147,929 | $0.00 | $0.00 |
| Jun 12, 2025 | Layding Martin | Chief Financial Officer | A | 414,439 | $0.00 | $0.00 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.3/10.
NEUTRAL
8-K
3/10
Vera Bradley board member Carrie Tharp will not stand for re-election at the 2026 shareholder meetin
Apr 24, 2026
NEUTRAL
8-K
3/10
Vera Bradley terminated its shareholder rights plan (poison pill) effective April 17, 2026, by accel
Apr 17, 2026
NEUTRAL
8-K
4/10
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Vera B
Mar 12, 2026
Current analyst consensus: Strong Sell (0% buy). Based on 8 analysts: 0 strong buy, 0 buy, 3 hold, 4 sell, 1 strong sell.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-04-30 |
$-0.33 | $-0.33 | $-0.33 | 8.3% | +0.0% | — | $0.0B | -4.9% | 1 |
| Next Q 2026-07-31 |
$0.01 | $0.01 | $0.01 | 150.0% | +0.0% | — | $0.1B | 0.0% | 1 |
| Current FY 2027-01-31 |
$-0.34 | $-0.34 | $-0.34 | 42.4% | +0.0% | 0↑ 1↓ | $0.3B | -2.4% | 1 |
| Next FY 2028-01-31 |
$0.01 | $0.01 | $0.01 | 102.9% | +0.0% | — | $0.3B | 2.5% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.330 | |
| 7d ago | $-0.330 | |
| 30d ago | $-0.330 | |
| 60d ago | $-0.330 | |
| 90d ago | $0.000 | -0.330 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 4, 2026 | Small Cap Consumer Research | REITERATE | Hold | Hold |
| Jan 26, 2026 | Small Cap Consumer Research | REITERATE | Hold | Hold |
| Jan 7, 2026 | Small Cap Consumer Research | REITERATE | Hold | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% | |
| May 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Apr 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Mar 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 11, 2026
earnings_calendar
VRA Q1 2027 Earnings Scheduled — 2026-06-11
Apr 24, 2026
other
Board Member Carrie Tharp Announces She Will Not Be Standing for Re-Election at the 2026 Shareholder Meeting
BOARD MEMBER CARRIE THARP ANNOUNCES SHE WILL NOT BE STANDING FOR RE-ELECTION AT THE 2026 SHAREHOLDER MEETING
Apr 17, 2026
activist
Vera Bradley Terminates Existing Shareholder Rights Plan
Vera Bradley Terminates Existing Shareholder Rights Plan
Mar 12, 2026
earnings
Vera Bradley Announces Fourth Quarter Fiscal Year 2026 Results and Leadership Appointments
VERA BRADLEY ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS AND LEADERSHIP APPOINTMENTS
Mar 12, 2026
earnings_calendar
VRA Q4 2026 Earnings Scheduled — 2026-03-12